Belvedere Trading’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,473	Closed	-$101K	–	194
2022 Q1	$101K	Buy	+14,473	New	+$101K	﹤0.01%	122
2021 Q4	–	Hold	0	–	–	–	214
2021 Q3	–	Hold	0	–	–	–	247